BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10428802)

  • 1. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
    Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
    Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
    Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
    Toffalini F; Hellberg C; Demoulin JB
    J Biol Chem; 2010 Apr; 285(16):12268-78. PubMed ID: 20164181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of receptor tyrosine kinase activation in cancer.
    Du Z; Lovly CM
    Mol Cancer; 2018 Feb; 17(1):58. PubMed ID: 29455648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart.
    Haan S; Bahlawane C; Wang J; Nazarov PV; Muller A; Eulenfeld R; Haan C; Rolvering C; Vallar L; Satagopam VP; Sauter T; Wiesinger MY
    JAKSTAT; 2015; 4(1):e1062596. PubMed ID: 26413425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the PDGF signaling pathway in tumor treatment.
    Heldin CH
    Cell Commun Signal; 2013 Dec; 11():97. PubMed ID: 24359404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.
    Ames HM; Wang AA; Coughran A; Evaul K; Huang S; Graves CW; Soyombo AA; Ross TS
    Mol Cell Biol; 2013 Sep; 33(18):3580-93. PubMed ID: 23836884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis.
    Demoulin JB; Montano-Almendras CP
    Am J Blood Res; 2012; 2(1):44-56. PubMed ID: 22432087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.
    Medves S; Demoulin JB
    J Cell Mol Med; 2012 Feb; 16(2):237-48. PubMed ID: 21854543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK.
    Medves S; Noël LA; Montano-Almendras CP; Albu RI; Schoemans H; Constantinescu SN; Demoulin JB
    Haematologica; 2011 Oct; 96(10):1406-14. PubMed ID: 21685469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.
    Oravecz-Wilson KI; Philips ST; Yilmaz OH; Ames HM; Li L; Crawford BD; Gauvin AM; Lucas PC; Sitwala K; Downing JR; Morrison SJ; Ross TS
    Cancer Cell; 2009 Aug; 16(2):137-48. PubMed ID: 19647224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
    Wang J; Yu W; Cai Y; Ren C; Ittmann MM
    Neoplasia; 2008 Aug; 10(8):847-56. PubMed ID: 18670643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma.
    Charest A; Kheifets V; Park J; Lane K; McMahon K; Nutt CL; Housman D
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):916-21. PubMed ID: 12538861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
    Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
    Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
    Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
    EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
    Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
    J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
    Ross TS; Gilliland DG
    J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
    Ross TS; Bernard OA; Berger R; Gilliland DG
    Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.